Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lymphoma Treatments
Pharma
FDA casts doubt on Roche's Polivy filing in first-line lymphoma
The FDA raised uncertainties over a “modest” tumor progression benefit and a lack of a patient survival showing for Polivy.
Angus Liu
Mar 7, 2023 3:06pm
A new complaint emerges in BMS' contingent value rights lawsuit
Feb 23, 2022 1:10pm
BMS, Gilead lock horns in CAR-T for 2L lymphoma
Dec 11, 2021 8:30am
Epizyme follicular lymphoma campaign showcases interactive coach
Nov 18, 2021 10:47am
ADC taps commercial manufacturer for its new blood cancer med
May 25, 2021 10:52am
Gilead’s Kite taps Eisai vet to helm CAR-T commercial strategy
Jul 10, 2018 10:30am
